HomeCompareBIMSX vs JNJ

BIMSX vs JNJ: Dividend Comparison 2026

BIMSX yields 3.55% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BIMSX wins by $5.1K in total portfolio value
10 years
BIMSX
BIMSX
● Live price
3.55%
Share price
$11.05
Annual div
$0.39
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.2K
Annual income
$446.41
Full BIMSX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BIMSX vs JNJ

📍 BIMSX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBIMSXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIMSX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BIMSX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIMSX
Annual income on $10K today (after 15% tax)
$301.95/yr
After 10yr DRIP, annual income (after tax)
$379.45/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $324.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIMSX + JNJ for your $10,000?

BIMSX: 50%JNJ: 50%
100% JNJ50/50100% BIMSX
Portfolio after 10yr
$22.6K
Annual income
$637.09/yr
Blended yield
2.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BIMSX
No analyst data
Price Target
$17.50
+58.4% upside vs current
Range: $8.00 — $27.00
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIMSX buys
0
JNJ buys
0
No recent congressional trades found for BIMSX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBIMSXJNJ
Forward yield3.55%3.36%
Annual dividend / share$0.39$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$25.2K$20.0K
Annual income after 10y$446.41$827.78
Total dividends collected$4.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst price target$17.50$228.73

Year-by-year: BIMSX vs JNJ ($10,000, DRIP)

YearBIMSX PortfolioBIMSX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,055$355.24$10,676$355.77+$379.00BIMSX
2$12,196$367.03$11,407$389.39+$789.00BIMSX
3$13,428$378.42$12,198$426.53+$1.2KBIMSX
4$14,758$389.40$13,056$467.62+$1.7KBIMSX
5$16,191$399.95$13,987$513.12+$2.2KBIMSX
6$17,734$410.08$14,998$563.56+$2.7KBIMSX
7$19,395$419.79$16,098$619.52+$3.3KBIMSX
8$21,182$429.07$17,295$681.69+$3.9KBIMSX
9$23,103$437.94$18,599$750.82+$4.5KBIMSX
10$25,166$446.41$20,022$827.78+$5.1KBIMSX

BIMSX vs JNJ: Complete Analysis 2026

BIMSXStock

The fund normally invests at least 80% of its net assets in the following types of U.S. dollar-denominated debt obligations: U.S. government and other public-sector agencies, asset-backed and mortgage-backed obligations of U.S. and foreign issuers and corporate debt of U.S. and foreign issuers.

Full BIMSX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BIMSX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIMSX vs SCHDBIMSX vs JEPIBIMSX vs OBIMSX vs KOBIMSX vs MAINBIMSX vs ABBVBIMSX vs MRKBIMSX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.